Immunotherapy of cancer. Present status and future potential.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D001500:BCG Vaccine; D001803:Blood Transfusion; D006649:Histocompatibility Antigens; D006801:Humans; D006968:Hypersensitivity, Delayed; D007106:Immune Sera / Q000008:administration & dosage; D007110:Immunity, Active; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy; D037102:Lectins / Q000494:pharmacology; D017710:Lymphocyte Transfusion; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012334:RNA, Neoplasm; D014184:Transplantation, Homologous
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D006649:Histocompatibility Antigens; D007106:Immune Sera; D037102:Lectins; D012334:RNA, Neoplasm